UBS upgraded Angi Inc. from Sell to Neutral and set a new price target of $2.75 from $2.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/16/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 12/18/2024 | Overweight → Neutral | Analyst | |
| 11/13/2024 | $3.25 → $2.50 | Buy → Neutral | Goldman |
| 11/13/2024 | $3.25 → $2.00 | Buy → Neutral | Citigroup |
| 7/9/2024 | $3.25 | Mkt Outperform | JMP Securities |
| 2/15/2023 | $2.00 → $2.75 | Sell → Neutral | UBS |
| 12/13/2022 | $2.60 | Buy | Citigroup |
| 12/2/2022 | $2.00 | Sell | UBS |
4 - Angi Inc. (0001705110) (Issuer)